On December 8, 2025, Tianjin Hesheng Biotechnology Co., Ltd. (HS SynBio) (Tianjin) received “FDA has no questions” letter. This marks the official recognition of its HMO 2'-Fucosyllactose (2'-FL) as GRAS.

In Japan, foods with functional claims refer to products for which the seller files a notification with the Consumer Affairs Agency (CAA) before marketing. The seller must submit scientific evidence supporting the safety and functional effectiveness of the product and may display the related functional claims. Unlike foods for specified health purpose, foods with functional claims are primarily the responsibility of the seller, and the filing process is comparatively less complex.

On December 2, 2025, China National Center for Food Safety Risk Assessment (CFSA) issued 4 new food additives for public comments, including 1 new food nutrition enhancer, 1 food processing aid, 2 food additives with additional requirements for quality specifications. Comments are welcomed before January 2, 2026.

The recent approval of the Mycoprotein from Fusarium venenatum marks a significant milestone for Fushine Biotech. As the technical supporter, CIRS Group assisted the company throughout the entire application process. Previously, CIRS had already supported Fushine in securing U.S. market access for the same ingredient through the GRAS Notice. These approvals – both in China and the United States – not only reflect Fushine Biotech’s strong R&D capacity and high product quality, but also underscores CIRS Group’s professional expertise in global food regulatory compliance.

On November 27, 2025, National Health Commission of the People’s Republic of China (NHC) issued an announcement (No. 7 of 2025) for “Three New Foods” with 14 products approved, including 3 new food raw materials, 8 new food additives, and 3 food-related products.